Insulin-like growth factor-I (IGF-I) and IGF-II are polypeptides that stimulate cell growth, survival or differentiation. In plasma and other extracellular fluids, they occur complexed to IGF-binding proteins (IGFBPs), a family of proteins that modulate their biological activity. The IGFBPs also may regulate cell growth independent of binding IGFs, providing a flexible and versatile system of cell regulation. We have studied the regulation of IGFBP gene expression and the biological activities of the IGFBPs. (i) Transcription of IGFBP-1 is dynamically regulated in response to metabolic and hormonal changes. Glucocorticoids increase and insulin inhibits IGFBP-1 promoter activity in a rat hepatoma cell line. Adjacent cis-elements in the proximal promoter are responsible for this regulation. Maximal stimulation of IGFBP-1 promoter activity by glucocorticoids requires synergistic interactions between the glucocorticoid receptor and the liver-enriched transcription factors, hepatocyte nuclear factor (HNF)-1 alpha and -beta. Studies to define the molecular mechanisms by which insulin inhibits IGFBP-1 promoter activity suggest that the signal transduction pathway includes phosphatidylinositol 3-phosphate kinase, protein kinase B/Akt, and possibly p70S6 kinase, and may involve regulation of the interaction of a member of the FKHR subfamily of HNF-3/forkhead transcription factors to the insulin response element. (ii) The main reservoir of IGFs is a 150- kilodalton complex in plasma that contains IGFBP-3 and an acid- labile subunit (ALS). Formation of this complex is dependent on the induction of ALS transcription by growth hormone (GH). GH induction of mouse ALS promoter activity in rat hepatoma cells is mediated by the binding of the transcription factors, STAT5a and STAT5b, to a single cis-regulatory element that resembles a gamma interferon activated sequence (GAS). (iii) Biologically active IGFs are released from the 150-kDa plasma complex by limited proteolysis of IGFBP-3 to form a fragment that has decreased binding affinity for the IGFs. Serine proteases and matrix metalloproteinase 3 (MMP-3) are responsible for the proteolysis of IGFBP-3 in serum from nonpregnant and pregnant adult rats, and neonatal rats. The serine protease may initiate the activation of latent MMP precursor, with activated MMP directly degrading IGFBP-3. (iv) IGFBP-3 inhibits DNA synthesis in mink lung epithelial cells independent of its ability to bind IGFs; IGF:IGFBP-3 complexes are not inhibitory. Studies are in progress to characterize the IGFBP-3 receptor that mediates growth inhibition, and to determine whether intact IGFBP-3 or a proteolytic fragment is responsible for the observed inhibition.
| Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2017) Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med 377:1143-1155 |
| Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2012) Health benefits of gastric bypass surgery after 6 years. JAMA 308:1122-31 |
| Kolotkin, Ronette L; Davidson, Lance E; Crosby, Ross D et al. (2012) Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis 8:625-33 |
| Hammoud, Ahmad O; Walker, James M; Gibson, Mark et al. (2011) Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity (Silver Spring) 19:1118-23 |
| Kolotkin, Ronette L; LaMonte, Michael J; Litwin, Sheldon et al. (2011) Cardiorespiratory fitness and health-related quality of life in bariatric surgery patients. Obes Surg 21:457-64 |
| Wasmund, Stephen L; Owan, Theophilus; Yanowitz, Frank G et al. (2011) Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm 8:84-90 |
| Hunt, Steven C; Hasstedt, Sandra J; Xin, Yuanpei et al. (2011) Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity (Silver Spring) 19:2241-7 |
| Benraouane, Fethi; Litwin, Sheldon E (2011) Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol 26:555-61 |
| Adams, Ted D; Pendleton, Robert C; Strong, Michael B et al. (2010) Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) 18:121-30 |
| Hammoud, Ahmad; Carrell, Douglas T; Meikle, A Wayne et al. (2010) An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men. Fertil Steril 94:1734-8 |
Showing the most recent 10 out of 22 publications
